Serum KL-6 can distinguish between different phenotypes of severe COVID-19.

Hideta Nakamura,Kazuya Miyagi,Mariko Otsuki,Yuri Higure,Naoya Nishiyama,Takeshi Kinjo,Masashi Nakamatsu,Shusaku Haranaga,Masao Tateyama,Jiro Fujita

Serum KL-6 can distinguish between different phenotypes of severe COVID-19.

2020

Hideta Nakamura
Kazuya Miyagi
Mariko Otsuki
Yuri Higure
Naoya Nishiyama
Takeshi Kinjo
Masashi Nakamatsu
Shusaku Haranaga
Masao Tateyama
Jiro Fujita

We read the article by D'Alessandro Miriana et al. with great interest and appreciate their efforts to evaluate the role of serum Krebs von den Lungen-6 (KL-6) as a prognostic biomarker of severe coronavirus disease 2019 (COVID-19).1 This article is protected by copyright. All rights reserved.

Keywords:

Virology
Immunology
Coronavirus disease 2019
Biology
prognostic biomarker
severe acute respiratory syndrome coronavirus 2
Phenotype
2019 20 coronavirus outbreak

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations